AI Verdict
NEPH has stronger fundamentals based on our AI analysis.
NERV vs NEPH Fundamental Comparison
| Metric | NERV | NEPH |
|---|---|---|
| Revenue | $0.0 | $18.8M |
| Net Income | $-293.4M | $1.2M |
| Net Margin | N/A | 6.4% |
| ROE | N/A | 11.7% |
| ROA | -299.5% | 8.8% |
| Current Ratio | 36.28x | 4.06x |
| Debt/Equity | N/A | 0.01x |
| EPS | $-34.67 | $0.11 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NERV vs NEPH: Frequently Asked Questions
Is NERV or NEPH a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NEPH has stronger fundamentals. NERV is rated STRONG SELL (85% confidence) while NEPH is rated BUY (75% confidence). This is not investment advice.
How does NERV compare to NEPH fundamentally?
Minerva Neurosciences, Inc. has ROE of N/A vs NEPHROS INC's 11.7%. Net margins are N/A vs 6.4% respectively.
Which stock pays higher dividends, NERV or NEPH?
NERV has a dividend yield of N/A or no dividend while NEPH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NERV or NEPH for long term?
For long-term investing, consider that NERV has STRONG SELL rating with 85% confidence, while NEPH has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NERV vs NEPH?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NERV vs NEPH, the AI consensus favors NEPH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.